ERBB2 and breast carcinoma: In particular, we have characterized signaling pathways by which the ErbB2/HER2 receptor tyrosine kinase regulates the cortical localization of EB1-binding proteins, allowing capture and stabilization of EB1-decorated microtubules at the leading edge of migrating breast cancer cells [16–19].